Economic Evaluation of New MDR TB Regimens
Condition(s):Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary TuberculosesLast Updated:May 14, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary TuberculosesLast Updated:May 14, 2021Unknown status
Condition(s):Multidrug Resistant TuberculosisLast Updated:July 14, 2015Unknown status
Condition(s):Multidrug Resistant TuberculosisLast Updated:July 30, 2018Not yet recruiting
Condition(s):Tuberculosis Multi Drug Resistant ActiveLast Updated:September 11, 2017Withdrawn
Condition(s):Multi-drug Resistant TuberculosisLast Updated:October 12, 2022Completed
Condition(s):Tuberculosis, Multidrug-Resistant; Infection, Bacterial; Pulmonary TuberculosesLast Updated:August 23, 2023Completed
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:February 4, 2019Unknown status
Condition(s):MDR-TBLast Updated:September 28, 2023Completed
Condition(s):Tuberculosis, Multidrug-Resistant; Tuberculosis; Pulmonary Tuberculoses; Mycobacterial Infections; Bacterial Infections; Gram-Positive Bacterial InfectionsLast Updated:July 21, 2023Active, not recruiting
Condition(s):Tuberculosis, PulmonaryLast Updated:February 13, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.